Volker Knappertz - Feb 20, 2024 Form 4 Insider Report for Aurinia Pharmaceuticals Inc. (AUPH)

Role
EVP, Research and Development
Signature
/s/ Volker Knappertz, M.D.
Stock symbol
AUPH
Transactions as of
Feb 20, 2024
Transactions value $
-$137,800
Form type
4
Date filed
2/22/2024, 04:35 PM
Previous filing
Mar 6, 2023
Next filing
Feb 29, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AUPH Common Stock Sale -$138K -25.1K -7.2% $5.48 324K Feb 20, 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of RSUs granted on August 1, 2022 grant.
F2 Includes shares of common stock acquired by the reporting person pursuant to the Issuer's 2021 Employee Share Purchase Plan as follows: 2,500 shares of common stock were acquired on May 31, 2023 and 2,430 shares of common stock were acquired on November 30, 2023.